Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1991 Apr;50(4):255–256. doi: 10.1136/ard.50.4.255

Pure red cell aplasia caused by D-penicillamine treatment of rheumatoid arthritis.

M Tishler 1, Y Kahn 1, M Yaron 1
PMCID: PMC1004397  PMID: 1903031

Abstract

A 40 year old woman with rheumatoid arthritis developed pure red cell aplasia after treatment with D-penicillamine 500 mg/day. D-Penicillamine was stopped and short term treatment with steroids resulted in complete recovery of bone marrow.

Full text

PDF
255

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dessypris E. N., Baer M. R., Sergent J. S., Krantz S. B. Rheumatoid arthritis and pure red cell aplasia. Ann Intern Med. 1984 Feb;100(2):202–206. doi: 10.7326/0003-4819-100-2-202. [DOI] [PubMed] [Google Scholar]
  2. Fishel B., Tishler M., Caspi D., Yaron M. Fatal aplastic anaemia and liver toxicity caused by D-penicillamine treatment of rheumatoid arthritis. Ann Rheum Dis. 1989 Jul;48(7):609–610. doi: 10.1136/ard.48.7.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gollan J. L., Hussein S., Hoffbrand A. V., Sherlock S. Red cell aplasia following prolonged D-penicillamine therapy. J Clin Pathol. 1976 Feb;29(2):135–139. doi: 10.1136/jcp.29.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kay A. G. Myelotoxicity of D-penicillamine. Ann Rheum Dis. 1979 Jun;38(3):232–236. doi: 10.1136/ard.38.3.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Krantz S. B., Moore W. H., Zaentz S. D. Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma. J Clin Invest. 1973 Feb;52(2):324–336. doi: 10.1172/JCI107188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Magnus J. H., Gran J. T., Mikkelsen K., Nygaard H., Brath H. K. Toxicity to D-penicillamine in rheumatoid arthritis. Scand J Rheumatol. 1987;16(6):441–444. doi: 10.3109/03009748709165417. [DOI] [PubMed] [Google Scholar]
  7. McGrath B. P., Ibels L. S., Raik E., Hargrave M. J. Erythroid toxicity of azathioprin. Macrocytosis and selective marrow hypoplasis. Q J Med. 1975 Jan;44(173):57–63. [PubMed] [Google Scholar]
  8. Michalevicz R., Baron S., Blum I. Fenbufen induced pure red cell aplasia in rheumatoid arthritis. J Rheumatol. 1987 Dec;14(6):1174–1176. [PubMed] [Google Scholar]
  9. Reid G., Patterson A. C. Pure red-cell aplasia after gold treatment. Br Med J. 1977 Dec 3;2(6100):1457–1457. doi: 10.1136/bmj.2.6100.1457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Stein H. B., Patterson A. C., Offer R. C., Atkins C. J., Teufel A., Robinson H. S. Adverse effects of D-penicillamine in rheumatoid arthritis. Ann Intern Med. 1980 Jan;92(1):24–29. doi: 10.7326/0003-4819-92-1-24. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES